Efficacy of Acamprosate for the Treatment of Alcohol Dependence After Recovery From Withdrawal Syndrome

Trial Profile

Efficacy of Acamprosate for the Treatment of Alcohol Dependence After Recovery From Withdrawal Syndrome

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Oct 2015

At a glance

  • Drugs Acamprosate (Primary)
  • Indications Alcoholism
  • Focus Therapeutic Use
  • Acronyms SUNRISE
  • Sponsors Nippon Shinyaku
  • Most Recent Events

    • 16 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top